Lispro 10 mg Johnlee Pharmaceuticals
€241.00
General introduction and principle of operation (Lispro 10 mg Johnlee Pharmaceuticals)
Lispro 10 mg, developed by Johnlee Pharmaceuticals, is a fast-acting insulin formulation designed to effectively manage blood sugar levels in individuals with diabetes. Its rapid absorption into the bloodstream allows for timely manipulation of blood glucose concentrations following meals. Understanding the underlying principles of this medication is crucial for effective diabetes management.
Insulin works by facilitating the uptake of glucose into cells, thereby lowering blood glucose levels. Lispro, specifically, is uniquely structured to mimic the natural insulin response, providing a swift onset of action that typically begins within 15 minutes after administration. This rapid action helps users control postprandial (after-meal) hyperglycemia, making it an invaluable component of diabetes management strategies.
Main components and active substances
The effectiveness of Lispro 10 mg is derived from its active ingredients and formulation components. Understanding these components is essential for evaluating the product’s efficacy and safety profile.
- Active Substance: Insulin Lispro – This is a rapid-acting insulin analog that plays a central role in glucose metabolism.
- Chemical Composition – The formula of Lispro is C257H383N65O77S6, designed specifically to exhibit a rapid action profile.
- Excipients – Various preservatives and stabilizers are included to ensure the stability and effectiveness of the medication over time.
- Storage Requirements – The insulin must be kept under refrigeration, specifically between 2-8 degrees Celsius to maintain its efficacy.
Mechanisms of action and expected results
The mechanisms through which Lispro 10 mg operates are integral to understanding how it aids in glucose regulation. The following actions are expected from its use:
- Rapid Glucose Uptake – Insulin Lispro facilitates glucose uptake by muscle and fat cells, effectively lowering blood glucose levels.
- Glycogen Synthesis Promotion – It helps in converting glucose into glycogen for storage, especially in the liver and muscle tissues.
- Inhibition of Gluconeogenesis – This action limits the production of glucose by the liver, further stabilizing blood glucose levels.
Recommendations for use
Lispro 10 mg should be administered with careful consideration to specific guidelines to maximize benefits and minimize risks. Proper usage includes:
- Timing of Administration – It is generally recommended to inject Lispro approximately 15 minutes before meals to manage postprandial blood sugar spikes effectively.
- Dosage Adjustments – Doses may vary based on individual insulin sensitivity, carbohydrate consumption, and blood glucose monitoring results.
- Regular Monitoring – Regular assessment of blood glucose levels is essential to tailor insulin therapy to individual needs.
Possible risks and contraindications (Lispro 10 mg Johnlee Pharmaceuticals)
While Lispro 10 mg can be highly effective, it also carries potential risks and contraindications that must be understood to ensure safe usage.
- Hypoglycemia – Overdosage can lead to dangerously low blood glucose levels.
- Allergic Reactions – Some patients may experience allergic responses, necessitating discontinuation and medical intervention.
- Weight Gain – Insulin therapy can lead to increased weight, which can complicate diabetes management.
- Contraindications – Individuals with certain medical conditions, like severe hypoglycemia, should avoid this medication.
| Active substance | Lisinopril |
|---|---|
| Classification | Angiotensin-converting Enzyme (ACE) Inhibitors |
| Water Retention | Can cause modest water retention |
| Hepatotoxicity | No hepatotoxic effects known |
| Lab Test | Blood insulin levels, C-peptide test |
| Also known as | Exogenous insulin |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can indirectly affect blood pressure by altering blood glucose levels |
| Trade name | Humulin, Novolin, Lantus, among others |
| Storage conditions | Must be kept refrigerated (2-8 degrees Celsius), avoid freezing |
| Chemical name | Insulin |
| Formula | C257H383N65O77S6 (for human insulin) |
| Substance class | Hormone, peptide |
| Main action | Lowers blood glucose levels |
| Half-life | Varies by type (Rapid-acting: 2-4 hours, Short-acting: 3-6 hours, Intermediate-acting: 12-18 hours, Long-acting: 20-24 hours) |
| Dosage (medical) | Depends on the patient's insulin sensitivity, carbohydrate intake, and blood glucose level, typically ranges from 0.5 to 1 unit/kg per day |
| Dosage (sports) | Not recommended for non-medical use |
| Effects | Decreases blood glucose, increases cellular glucose uptake, promotes glycogen synthesis |
| Side effects | Hypoglycemia, weight gain, insulin resistance, allergic reactions |
| Use in sports | Misused for anabolic purposes |
| Manufacturer | Johnlee Pharmaceuticals |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |




Reviews
There are no reviews yet.